Skip to search formSkip to main contentSkip to account menu

MVP regimen

National Institutes of Health

Related topics

Related topics

1 relation
Cisplatin-Mitomycin-Vinblastine Regimen

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
[Prospective randomized study of HMVP, MVP, and HVP regimens in treatment of advanced non-small cell lung cancer].
BACKGROUND & OBJECTIVE Non-small cell lung cancer (NSCLC) is hyposensitive to the normal first and second-line chemotherapy… 
2002
2002
Combination of Aidi Injection and MVP Regimen for Patients withAdvanced Non-small Cell Lung Cancer
  • P. Da
  • 2002
  • Corpus ID: 75641105
To compare the effect,toxicity and quality of life(QOL)between Aidi-MVP regimen and MVP regimen alone in primary patients with… 
1996
1996
Is the MVP regimen less active than previously described? Results of a phase II study in advanced non-small cell lung cancer.
Combination chemotherapy with anti-proliferative agents is often used in patients with advanced non-small cell lung cancer (NSCLC… 
1995
1995
1091 The MVP regimen could be less active and toxic than previously described: A divergent report on non-small cell lung cancer
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)